Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platino-resistance in Ovarian Cancer

NCT03954171 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT03954171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03954171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platino-resistance in Ovarian Cancer
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Recruiting
Start date
March 6, 2020
Completion date
March 31, 2033
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer